Ptc Therapeutics (PTCT) Debt Ratio (2012 - 2026)

Ptc Therapeutics' Debt Ratio history runs 15 years deep, the most recent figure standing at 0.11 for Q1 2026.

• On a quarterly basis, Debt Ratio fell 47.13% year-over-year to 0.11 in Q1 2026; TTM through Mar 2026 was 0.11, a 47.13% decrease from a year earlier, with the FY2025 full-year figure at 0.1, down 69.36% from the prior year.
• Debt Ratio advanced to 0.11 in Q1 2026 per PTCT's latest filing, from 0.1 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.54 in Q3 2023 and bottomed at 0.1 in Q4 2025.
• The 5-year median for Debt Ratio is 0.25 (2023), against an average of 0.27.
• Across the five-year window, Debt Ratio jumped 135.54% in 2023 and sank 69.36% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.38 in 2022, then tumbled by 33.13% to 0.25 in 2023, then advanced by 26.22% to 0.32 in 2024, then sank by 69.36% to 0.1 in 2025, then grew by 8.9% to 0.11 in 2026.
• Per Business Quant, the three latest PTCT Debt Ratio figures stand at 0.11 (Q1 2026), 0.1 (Q4 2025), and 0.11 (Q3 2025).